India's DCGI Goes To Supreme Court To Centralize Drug-Export Issue
This article was originally published in PharmAsia News
Executive Summary
The Drug Controller General of India is said to be planning to seek Supreme Court help in centralizing the agency's power to grant export-quality licenses to drug makers